Restructuring

Digicel ANNOUNCES successful closing of consensual RESTRUCTURING of ~$3.8BN OF THE GROUP'S DEBT, IN SUPPORT OF FUTURE GROWTH

Retrieved on: 
星期一, 一月 29, 2024

The completion of the Restructuring marks an important milestone for the Group, which now has a substantially strengthened capital structure, positioning the Group for long-term success.

Key Points: 
  • The completion of the Restructuring marks an important milestone for the Group, which now has a substantially strengthened capital structure, positioning the Group for long-term success.
  • As a result of the Restructuring, the Group extended certain secured and unsecured debt issued by Digicel International Finance Limited ("DIFL") and Digicel Intermediate Holdings Limited ("DIHL").
  • In addition, certain notes issued by Digicel Limited ("DL") and subordinated notes issued by DIFL were equitized.
  • In connection with the Restructuring, the board of directors of the reorganized Group has been reconstituted as a nine-member board, including Rajeev Suri as Chairman.

Update on Disclosed Matter: Mitsubishi Electric to Transfer Automotive-equipment Business to New Subsidiary as Part of Restructuring

Retrieved on: 
星期二, 十月 31, 2023

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will transfer its automotive-equipment business and assets to a future wholly owned subsidiary Melco Automotive Equipment Business Split Preparation Corporation (the “Prep Company”), through an absorption-type company split effective April 1, 2024 (scheduled) (the “Company Split”), following the announcement “Mitsubishi Electric to Restructure its Automotive-equipment Business” issued on April 24 of this year.

Key Points: 
  • Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will transfer its automotive-equipment business and assets to a future wholly owned subsidiary Melco Automotive Equipment Business Split Preparation Corporation (the “Prep Company”), through an absorption-type company split effective April 1, 2024 (scheduled) (the “Company Split”), following the announcement “Mitsubishi Electric to Restructure its Automotive-equipment Business” issued on April 24 of this year.
  • As the Company Split will take the form of a simplified absorption-type company split with a wholly owned subsidiary of Mitsubishi Electric, certain information is omitted from this announcement.
  • Mitsubishi Electric is implementing strategic measures appropriate to each of its target businesses in order to adjust its business portfolio and strengthen its business structure for improved profitability and asset utilization.
  • Mitsubishi Electric expects the Company Split to improve operational efficiency and enhance the portfolio of its automotive-equipment business for greater profitability.

World Cell and Gene Therapy Market Analysis Report 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals - ResearchAndMarkets.com

Retrieved on: 
星期五, 七月 7, 2023

The "Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals" report has been added to ResearchAndMarkets.com's offering.
  • This report tracks the dealmaking and market opportunity for cell and gene therapy companies.
  • A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently.
  • While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years.

Notice regarding Issuance of Stock-Compensation-Type Stock Options (Stock Acquisition Rights)

Retrieved on: 
星期三, 六月 28, 2023

TOKYO, June 28, 2023 (GLOBE NEWSWIRE) -- Internet Initiative Japan Inc. (“IIJ”, the “Company”, TSE Prime: 3774) announced that IIJ’s Board of Directors today resolved that stock-compensation-type stock options (Stock Acquisition Rights) be issued to Directors (excluding Part-time and Outside Directors) and Executive Officers of IIJ, in accordance with the provisions of Articles 236 Paragraph 1, Article 238 Paragraph 1 and 2 and Article 240 Paragraph 1 of the Corporation Law of Japan, as follows.

Key Points: 
  • Any acquisition of stock acquisition rights by transfer shall be subject to the approval by resolution of the Board of Directors of the Company.
  • The Company shall deliver stock acquisition rights, the number of which shall equal the number of stock acquisition rights held by the holder of the Remaining Stock Acquisition Rights.
  • Accordingly, the issuance of the stock acquisition rights is not an issuance of shares with favorable terms.
  • (14) Persons to be allotted stock acquisition rights, number of persons, and number of stock acquisition rights to be allotted

GoldenTree Announces Oversubscribed Distressed Fund IV

Retrieved on: 
星期二, 九月 27, 2022

GoldenTree Asset Management (GoldenTree), a global asset management firm with over $47 billion in assets under management, today announced the closing of its Distressed Fund IV.

Key Points: 
  • GoldenTree Asset Management (GoldenTree), a global asset management firm with over $47 billion in assets under management, today announced the closing of its Distressed Fund IV.
  • Distressed Fund IV reached its hard cap with commitments of $3 billion and was oversubscribed.
  • Fund IV seeks superior risk-adjusted returns by investing in distressed, stressed and special situation assets.
  • The size of our investors commitment to our distressed funds has grown significantly since Distressed Fund I in 2010.

Notice regarding Issuance of Stock-Compensation-Type Stock Options (Stock Acquisition Rights)

Retrieved on: 
星期二, 六月 28, 2022

Any acquisition of stock acquisition rights by transfer shall be subject to the approval by resolution of the Board of Directors of the Company.

Key Points: 
  • Any acquisition of stock acquisition rights by transfer shall be subject to the approval by resolution of the Board of Directors of the Company.
  • The Company shall deliver stock acquisition rights, the number of which shall equal the number of stock acquisition rights held by the holder of the Remaining Stock Acquisition Rights.
  • Accordingly, the issuance of the stock acquisition rights is not an issuance of shares with favorable terms.
  • Persons to be allotted stock acquisition rights, number of persons, and number of stock acquisition rights to be allotted

Shareholders Approve Inter's Corporate Reorganization and Migration to Nasdaq

Retrieved on: 
星期五, 五月 13, 2022

BELO HORIZONTE, Brazil, May 12, 2022 /PRNewswire/ -- Banco Inter S.A. (B3: BIDI3, BIDI4 and BIDI11) ("Inter"), a leading super app, offering financial and non-financial services to more than 18 million customers in Brazil, announced that during its Extraordinary General Meeting (EGM) held today, the Company's proposal for Corporate Reorganization was approved by more than 85% of the total outstanding shares present. The US Securities and Exchange Commission (SEC) had already approved earlier this month the amendment to the registration statement submitted by Inter&Co.

Key Points: 
  • Joo Vitor Menin, Inter's CEO, said: "I would like to thank all shareholders who participated and approved the corporate reorganization during today's EGM.
  • As a result, Inter will shift its listing to Nasdaq in an unprecedented transaction in Brazil.
  • Following the corporate reorganization, Inter's controlling shareholder will directly control Inter&Co and indirectly control Inter through ownership of Class B Shares, which are entitled to 10 votes per share.
  • The company has a broad credit portfolio of R$16.8 billion, shareholders' equity of R$8.6 billion, and R$36.5 billion in total assets as of December 31, 2021.

Schulte Roth & Zabel Strengthens Business Reorganization Group with Addition of Ned S. Schodek

Retrieved on: 
星期二, 三月 8, 2022

NEW YORK, March 8, 2022 /PRNewswire/ -- Schulte Roth & Zabel today announced that Ned S. Schodek has joined the firm as a partner in the Business Reorganization Group, based in the New York office.

Key Points: 
  • NEW YORK, March 8, 2022 /PRNewswire/ -- Schulte Roth & Zabel today announced that Ned S. Schodek has joined the firm as a partner in the Business Reorganization Group, based in the New York office.
  • "We are so excited Ned is joining us," said Douglas Mintz, Partner and Co-Chair of SRZ's Business Reorganization Group.
  • "Ned joins a Business Reorganization group that has seen client demand for our services double since 2020.
  • Schulte Roth & Zabel LLP ( www.srz.com ) is a full-service law firm with offices in New York, Washington, DC and London.

Restructure This! Highlights Current Issues and Developments in Corporate Restructuring

Retrieved on: 
星期三, 一月 19, 2022

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce the launch of Restructure This!, a new podcast hosted by Sheppard Mullin partner Justin Bernbrock and featuring Sheppard Mullin restructuring attorneys Bryan Uelk, Catherine Jun, and Robert McLellarn, that focuses on issues and developments in the corporate restructuring industry.

Key Points: 
  • Sheppard, Mullin, Richter & Hampton LLP is pleased to announce the launch of Restructure This!, a new podcast hosted by Sheppard Mullin partner Justin Bernbrock and featuring Sheppard Mullin restructuring attorneys Bryan Uelk, Catherine Jun, and Robert McLellarn, that focuses on issues and developments in the corporate restructuring industry.
  • features an in-depth interview with a high-profile member of the restructuring industry, including leading attorneys, financial advisors, investment bankers, and distressed debt investors.
  • draws out controversy, humor, and unique insights that are relevant to anyone interested in learning more about the world of corporate restructuring.
  • Since companies that were going to restructure find themselves with access to more liquidity, whats next for restructuring?

Gain Therapeutics Presents Parkinson’s Disease Preclinical Study Results at Society for Neuroscience Annual Meeting

Retrieved on: 
星期四, 十一月 11, 2021

We are working diligently to advance this breakthrough compound to the clinic and bring it one step closer to meeting the currently unaddressed needs of patients with this debilitating disease.

Key Points: 
  • We are working diligently to advance this breakthrough compound to the clinic and bring it one step closer to meeting the currently unaddressed needs of patients with this debilitating disease.
  • Parkinsons Disease is a neurodegenerative disease affecting millions of people worldwide.
  • PD patients with GBA1 mutations have an early onset of the disease, faster progression, and non-motor symptoms.
  • In July 2020, Gain Therapeutics, Inc. completed a share exchange with Gain Therapeutics, SA, a Swiss corporation, whereby GT Gain Therapeutics SA became a wholly owned subsidiary of Gain Therapeutics, Inc. For periods and at dates prior to the Corporate Reorganization, the consolidated financial statements were prepared based on the historical financial statements of GT Gain Therapeutics SA.